Eiryo Kawakami

Eiryo Kawakami

Auto-generated profile, based on publicly available information

Eiryo Kawakami

Chiba University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TATiffany Amariuta
Tiffany Amariuta
KIKazuyoshi Ishigaki
Kazuyoshi Ishigaki
HSHiroki Sugishita
Hiroki Sugishita
TOTazro Ohta
Tazro Ohta
MKMasaru Koido
Masaru Koido
SRSoumya Raychaudhuri
Soumya Raychaudhuri

30 November 2023 in JMIR Medical Education
Verified
Journal Article
Open access
ISIkuo Shimizu
Ikuo Shimizu
HKHajime Kasai
Hajime Kasai
KSKiyoshi Shikino
Kiyoshi Shikino
NANobuyuki Araki
Nobuyuki Araki
ZTZaiya Takahashi
Zaiya Takahashi
EKEiryo Kawakami
Eiryo Kawakami
Background: Generative artificial intelligence (GAI), represented by large language models, have the potential to transform health care and medical education. In particular, GAI’s impact on higher education has the potential to change students’ learning experience as well as faculty’s teaching. However, concerns have been raised about ethical consideration and decreased reliability of the existing examinations. Furthermore, in medical education, curriculum reform is required to adapt to the revolutionary changes brought about by the integration of GAI into medical practice and research. Objective: This study analyzes the impact of GAI on medical education curricula and explores strategies for adaptation. Methods: The study was conducted in the context of faculty development at a medical school in Japan. A workshop involving faculty and students was organized, and participants were divided into groups to address two research questions: (1) How does GAI affect undergraduate medical education curricula? and (2) How should medical school curricula be reformed to address the impact of GAI? The strength, weakness, opportunity, and threat (SWOT) framework was used, and cross-SWOT matrix analysis was used to devise strategies. Further, 4 researchers conducted content analysis on the data generated during the workshop discussions. Results: The data were collected from 8 groups comprising 55 participants. Further, 5 themes about the impact of GAI on medical education curricula emerged: improvement of teaching and learning, improved access to information, inhibition of existing learning processes, problems in GAI, and changes in physicians’ professionality. Positive impacts included enhanced teaching and learning efficiency and improved access to information, whereas negative impacts included concerns about reduced independent thinking and the adaptability of existing assessment methods. Further, GAI was perceived to change the nature of physicians’ expertise. Three themes emerged from the cross-SWOT analysis for curriculum reform: (1) learning about GAI, (2) learning with GAI, and (3) learning aside from GAI. Participants recommended incorporating GAI literacy, ethical considerations, and compliance into the curriculum. Learning with GAI involved improving learning efficiency, supporting information gathering and dissemination, and facilitating patient involvement. Learning aside from GAI emphasized maintaining GAI-free learning processes, fostering higher cognitive domains of learning, and introducing more communication exercises. Conclusions: This study highlights the profound impact of GAI on medical education curricula and provides insights into curriculum reform strategies. Participants recognized the need for GAI literacy, ethical education, and adaptive learning. Further, GAI was recognized as a tool that can enhance efficiency and involve patients in education. The study also suggests that medical education should focus on competencies that GAI hardly replaces, such as clinical experience and communication. Notably, involving both faculty and students in curriculum reform discussions fosters a sense of ownership and ensures broader perspectives are encompassed.

12 October 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TITakeshi Inoue
Takeshi Inoue
RSRyo Shinnakasu
Ryo Shinnakasu
CKChie Kawai
Chie Kawai
WIWataru Ise
Wataru Ise
EKEiryo Kawakami
Eiryo Kawakami
TKTomohiro Kurosaki
Tomohiro Kurosaki
A still unanswered question is what drives the small fraction of activated germinal center (GC) B cells to become long-lived quiescent memory B cells. We found here that a small population of GC-derived CD38intBcl6hi/intEfnb1+ cells with lower mTORC1 activity favored the memory B cell fate. Constitutively high mTORC1 activity led to defects in formation of the CD38intBcl6hi/intEfnb1+ cells; conversely, decreasing mTORC1 activity resulted in relative enrichment of this memory-prone population over the recycling-prone one. Furthermore, the CD38intBcl6hi/intEfnb1+ cells had higher levels of Bcl2 and surface BCR that, in turn, contributed to their survival and development. We also found that downregulation of Bcl6 resulted in increased expression of both Bcl2 and BCR. Given the positive correlation between the strength of T cell help and mTORC1 activity, our data suggest a model in which weak help from T cells together with provision of an increased survival signal are key for GC B cells to adopt a memory B cell fate.

1 April 2021 in Cell Reports
Verified
Journal Article
Open access
YIYoshihiro Ito
Yoshihiro Ito
TSTakashi Sasaki
Takashi Sasaki
YLYouxian Li
Youxian Li
TTTakeshi Tanoue
Takeshi Tanoue
Yuki SugiuraYuki Sugiura
Yuki Sugiura
KHKenya Honda
Kenya Honda
Host-microbe interactions orchestrate skin homeostasis, the dysregulation of which has been implicated in chronic inflammatory conditions such as atopic dermatitis and psoriasis. Here, we show that Staphylococcus cohnii is a skin commensal capable of beneficially inhibiting skin inflammation. We find that Tmem79-/- mice spontaneously develop interleukin-17 (IL-17)-producing T-cell-driven skin inflammation. Comparative skin microbiome analysis reveals that the disease activity index is negatively associated with S. cohnii. Inoculation with S. cohnii strains isolated from either mouse or human skin microbiota significantly prevents and ameliorates dermatitis in Tmem79-/- mice without affecting pathobiont burden. S. cohnii colonization is accompanied by activation of host glucocorticoid-related pathways and induction of anti-inflammatory genes in the skin and is therefore effective at suppressing inflammation in diverse pathobiont-independent dermatitis models, including chemically induced, type 17, and type 2 immune-driven models. As such, S. cohnii strains have great potential as effective live biotherapeutics for skin inflammation.

2 June 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
AFAyano Fukushima-Nomura
Ayano Fukushima-Nomura
HKHiroshi Kawasaki
Hiroshi Kawasaki
KYKiyoshi Yashiro
Kiyoshi Yashiro
SOShoko Obata
Shoko Obata
KTKeiji Tanese
Keiji Tanese
MAMasayuki Amagai
Masayuki Amagai
Atopic dermatitis (AD) is a skin disease exhibiting clinical and molecular heterogeneity, thereby jeopardizing the development of personalized treatments. Here we pursue a cross-sectional and longitudinal cohort analysis of 951 whole-skin samples, employing an unsupervised decomposition analysis to link gene expression profiles to disease severity, six distinct skin phenotypes, and blood cytokines representative of given endotypes. Specifically, type 2 and type 17 responses are associated with major skin phenotypes such as erythema and induration, while type 1 response is upregulated in lichen amyloidosis of AD patients. Longitudinal analysis of patients treated with dupilumab finds sustained gene signatures related to type 17 response in lesional skin and upregulated transcription factors in non-lesional skin of patients with poor treatment outcomes. Lastly, several extracellular matrix organization-associated genes are correlated with clinical severity and treatment response to dupilumab. Our findings thus provide potential skin and blood biomarkers for assessing endotypes and therapeutic responses in AD to pave the way for personalized medicine.

9 September 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
HSHiroki Sugishita
Hiroki Sugishita
TKTakashi Kondo
Takashi Kondo
SIShinsuke Ito
Shinsuke Ito
MNManabu Nakayama
Manabu Nakayama
NYNayuta Yakushiji-Kaminatsui
Nayuta Yakushiji-Kaminatsui
HKHaruhiko Koseki
Haruhiko Koseki
Polycomb repressive complexes-1 and -2 (PRC1 and 2) silence developmental genes in a spatiotemporal manner during embryogenesis. How Polycomb group (PcG) proteins orchestrate down-regulation of target genes upon differentiation, however, remains elusive. Here, by differentiating embryonic stem cells into embryoid bodies, we reveal a crucial role for the PCGF1-containing variant PRC1 complex (PCGF1-PRC1) to mediate differentiation-associated down-regulation of a group of genes. Upon differentiation cues, transcription is down-regulated at these genes, in association with PCGF1-PRC1-mediated deposition of histone H2AK119 mono-ubiquitination (H2AK119ub1) and PRC2 recruitment. In the absence of PCGF1-PRC1, both H2AK119ub1 deposition and PRC2 recruitment are disrupted, leading to aberrant expression of target genes. PCGF1-PRC1 is, therefore, required for initiation and consolidation of PcG-mediated gene repression during differentiation.